MicroRNA-130b-5p accelerates the migration and invasion of osteosarcoma via binding to TIMP2

Z-H Cheng1, C Luo, Z-L Guo

  • 1Department of Neurosurgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, China. gzlysr@outlook.com.

Abstract

Insights

MicroRNA-130b-5p is elevated in osteosarcoma (OS) and promotes cancer progression. This microRNA accelerates OS cell migration and invasion by inhibiting TIMP2, a key regulator.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Osteosarcoma (OS) is a primary bone malignancy with a significant impact on patient prognosis.
  • MicroRNAs (miRNAs) are emerging as critical regulators in various cancers, including OS.
  • Understanding the specific roles of miRNAs in OS progression is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the functional role of microRNA-130b-5p (miR-130b-5p) in osteosarcoma.
  • To elucidate the molecular mechanism by which miR-130b-5p influences OS progression.
  • To assess the correlation between miR-130b-5p expression and patient outcomes.

Main Methods:

  • Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR) to measure miR-130b-5p levels in OS tissues and cell lines.
  • Transwell assays to evaluate the effects of miR-130b-5p on cell migration and invasion.
  • Western blotting and dual-luciferase reporter assays to identify and validate miR-130b-5p targets.
  • Rescue experiments to confirm the functional significance of the miR-130b-5p/TIMP2 axis.

Main Results:

  • miR-130b-5p was significantly upregulated in OS tissues and cell lines.
  • High miR-130b-5p expression correlated with poor prognosis in OS patients.
  • Overexpression of miR-130b-5p enhanced OS cell migration and invasion, partly through upregulation of MMP2 and MMP9.
  • TIMP2 was identified as a direct target of miR-130b-5p, with miR-130b-5p negatively regulating TIMP2 expression.
  • Knockdown of TIMP2 partially reversed the pro-migratory and pro-invasive effects induced by miR-130b-5p.

Conclusions:

  • miR-130b-5p is oncogenic in osteosarcoma.
  • miR-130b-5p promotes OS progression by targeting and inhibiting TIMP2.
  • Targeting the miR-130b-5p/TIMP2 pathway may represent a therapeutic strategy for osteosarcoma.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.7K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.2K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.1K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K